ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 414 filers reported holding ENCOMPASS HEALTH CORP in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,185,000 | -16.6% | 28,000 | -12.5% | 0.07% | -21.3% |
| Q1 2021 | $2,619,000 | -5.6% | 31,984 | -4.7% | 0.09% | -4.3% |
| Q4 2020 | $2,775,000 | +20.3% | 33,559 | -5.5% | 0.09% | +9.4% |
| Q3 2020 | $2,306,000 | -5.1% | 35,494 | -9.5% | 0.08% | -8.6% |
| Q2 2020 | $2,429,000 | -38.4% | 39,215 | -36.3% | 0.09% | -40.0% |
| Q1 2020 | $3,943,000 | -19.9% | 61,579 | -13.3% | 0.16% | -2.5% |
| Q4 2019 | $4,920,000 | -8.6% | 71,031 | -16.5% | 0.16% | -9.7% |
| Q3 2019 | $5,383,000 | -19.7% | 85,071 | -19.6% | 0.18% | -18.1% |
| Q2 2019 | $6,706,000 | -8.7% | 105,846 | -15.9% | 0.22% | -8.9% |
| Q1 2019 | $7,349,000 | -11.7% | 125,844 | -6.7% | 0.24% | -16.0% |
| Q4 2018 | $8,324,000 | -11.5% | 134,904 | +11.8% | 0.28% | +5.6% |
| Q3 2018 | $9,409,000 | -7.3% | 120,704 | -19.5% | 0.27% | -43.0% |
| Q2 2018 | $10,152,000 | +18.2% | 149,915 | -0.2% | 0.47% | +21.3% |
| Q1 2018 | $8,590,000 | – | 150,255 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |